Warren Grant Megnuson Clinical Center - NCI Clinical Trials Referral Office

Bethesda, Maryland 20892

We've found

3 trials

at this facility

Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease

Status: Enrolling, Phase I
Updated: 8/10/2007

from

Bethesda, MD

Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease

Status: Enrolling, Phase I
Updated: 4/16/2007

from

Bethesda, MD

Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease

Status: Enrolling, Phase I
Updated: 4/16/2007

from

Bethesda, MD

Use our guide to learn which trials are right for you!